Phase 2 Advanced Nasopharyngeal Carcinoma Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
Consolidation Nivolumab After Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma
Locally Advanced Nasopharyngeal Carcinoma
Yonsei University57 enrolled1 locationNCT04910347
Recruiting
Phase 2
Iparomlimab/Tuvorlimab (QL1706) and Modified TPF Regimen for Induction Therapy in LANPC
ImmunotherapyInduction TherapyLocally Advanced Nasopharyngeal Carcinoma
The First Affiliated Hospital of Xiamen University30 enrolled1 locationNCT07085234
Recruiting
Phase 2
SBRT Combined With Chemotherapy and Tislelizumab in Metastatic NPC
Advanced Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital37 enrolled1 locationNCT05652192
Recruiting
Phase 2
Envafolimab Plus Chemoradiotherapy for Locally Advanced NPC, a Prospective, Single Armed Phase II Trial.
PD-L1Locally Advanced Nasopharyngeal CarcinomaInduction Chemotherapy+1 more
Sun Yat-sen University36 enrolled1 locationNCT05397769